Pure Global AI
NCT06422169Recruiting

Interventistic Clinical Investigation on the Use of Medical Device in Subjects With Mild-moderate Osteoarticular Pain

Interventistic Monocentric Pre-market Clinical Investigation on the Use of Medical Device ArToFILL in Subjects With Mild-moderate Osteoarticular Pain
PromoPharma spaClinicalTrials.govdeviceDevice trial
Study focus
Disease/Condition
Osteoarthritis, Knee
Drug/Device/Intervention
ArToFILL
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
PromoPharma spa
Location
Catania, Italy
Timeline & enrollment
Phase
N/A
Start date
May 08, 2024
End date
May 08, 2025
Enrollment
35 participants
Primary outcome

Reduction ≥ of 15 points on VAS scale, at the Study Termination Visit compared to baseline

Summary

Evaluation of the performance and safety of ArToFILL in subjects with mild to moderate
 osteoarticular pain

ICD-10 classifications
Chronic instability of kneeInjuries to the knee and lower legGonarthrosis [arthrosis of knee]Dislocation, sprain and strain of joints and ligaments of kneeSprain and strain of other and unspecified parts of knee
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06422169
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06422169 through Pure Global AI's free database. This phase not specified trial is sponsored by PromoPharma spa and is currently Recruiting. The study focuses on Osteoarthritis, Knee. Target enrollment is 35 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.